Maxim Pimkin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
IMP Dehydrogenase | 3 | 2009 | 34 | 0.940 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2022 | 3626 | 0.660 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 308 | 0.640 |
Why?
|
Thrombopoiesis | 3 | 2014 | 160 | 0.610 |
Why?
|
Erythropoiesis | 3 | 2014 | 691 | 0.510 |
Why?
|
Endonucleases | 2 | 2007 | 371 | 0.440 |
Why?
|
Interferon Regulatory Factors | 2 | 2022 | 271 | 0.360 |
Why?
|
Escherichia coli | 4 | 2009 | 4209 | 0.320 |
Why?
|
Purine Nucleotides | 1 | 2008 | 27 | 0.300 |
Why?
|
RNA, Ribosomal | 3 | 2023 | 227 | 0.300 |
Why?
|
Spinacia oleracea | 1 | 2007 | 11 | 0.290 |
Why?
|
Alphaproteobacteria | 1 | 2006 | 11 | 0.270 |
Why?
|
Cell Lineage | 2 | 2014 | 2575 | 0.260 |
Why?
|
DNA, Ribosomal | 2 | 2023 | 300 | 0.240 |
Why?
|
DNA, Single-Stranded | 1 | 2006 | 351 | 0.220 |
Why?
|
Adenosine | 1 | 2009 | 812 | 0.220 |
Why?
|
RNA Polymerase I | 1 | 2022 | 23 | 0.210 |
Why?
|
Escherichia coli Proteins | 2 | 2009 | 1055 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3408 | 0.200 |
Why?
|
GATA1 Transcription Factor | 2 | 2014 | 306 | 0.190 |
Why?
|
Transcription Factors | 3 | 2022 | 12158 | 0.180 |
Why?
|
Cell Differentiation | 3 | 2014 | 11657 | 0.170 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2014 | 1144 | 0.170 |
Why?
|
RNA | 3 | 2023 | 2715 | 0.160 |
Why?
|
Immunophenotyping | 1 | 2024 | 1864 | 0.160 |
Why?
|
beta-Lactamases | 3 | 2008 | 307 | 0.160 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4114 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2022 | 1442 | 0.150 |
Why?
|
GATA2 Transcription Factor | 2 | 2014 | 158 | 0.140 |
Why?
|
Gene Rearrangement | 1 | 2022 | 1141 | 0.140 |
Why?
|
Genome | 2 | 2023 | 1752 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1232 | 0.130 |
Why?
|
Binding Sites | 3 | 2014 | 6014 | 0.120 |
Why?
|
GATA Transcription Factors | 1 | 2014 | 28 | 0.120 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 104 | 0.110 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4838 | 0.110 |
Why?
|
Molecular Sequence Annotation | 2 | 2014 | 526 | 0.110 |
Why?
|
Chromatin | 4 | 2023 | 2980 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2014 | 313 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4522 | 0.110 |
Why?
|
Megakaryocyte Progenitor Cells | 1 | 2013 | 27 | 0.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1559 | 0.100 |
Why?
|
Megakaryocytes | 2 | 2014 | 557 | 0.100 |
Why?
|
Calcineurin | 1 | 2013 | 235 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2330 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2009 | 3760 | 0.090 |
Why?
|
Databases, Nucleic Acid | 1 | 2012 | 203 | 0.090 |
Why?
|
NFATC Transcription Factors | 1 | 2013 | 393 | 0.090 |
Why?
|
Cluster Analysis | 2 | 2014 | 2721 | 0.090 |
Why?
|
Gene Silencing | 2 | 2014 | 1505 | 0.090 |
Why?
|
Recurrence | 1 | 2022 | 8504 | 0.080 |
Why?
|
Protein Conformation | 2 | 2009 | 3948 | 0.080 |
Why?
|
Trichomonas | 1 | 2009 | 3 | 0.080 |
Why?
|
Cations, Monovalent | 1 | 2009 | 24 | 0.080 |
Why?
|
Species Specificity | 2 | 2014 | 2412 | 0.080 |
Why?
|
GMP Reductase | 1 | 2008 | 3 | 0.080 |
Why?
|
Adenylosuccinate Synthase | 1 | 2008 | 3 | 0.080 |
Why?
|
Phosphorus Radioisotopes | 1 | 2008 | 100 | 0.080 |
Why?
|
Inosine | 1 | 2009 | 129 | 0.080 |
Why?
|
Models, Molecular | 2 | 2009 | 5388 | 0.080 |
Why?
|
Cephalosporin Resistance | 1 | 2008 | 17 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4357 | 0.070 |
Why?
|
Immunotherapy | 1 | 2024 | 4745 | 0.070 |
Why?
|
Ceftazidime | 1 | 2008 | 57 | 0.070 |
Why?
|
Gene Expression Profiling | 4 | 2024 | 9532 | 0.070 |
Why?
|
Conserved Sequence | 2 | 2014 | 1160 | 0.070 |
Why?
|
Mice | 9 | 2023 | 81912 | 0.070 |
Why?
|
Protein Binding | 3 | 2014 | 9327 | 0.070 |
Why?
|
Models, Biological | 3 | 2014 | 9464 | 0.070 |
Why?
|
Histones | 2 | 2014 | 2597 | 0.070 |
Why?
|
Guanosine Triphosphate | 1 | 2008 | 315 | 0.070 |
Why?
|
Catalysis | 1 | 2009 | 766 | 0.070 |
Why?
|
Carbon Radioisotopes | 1 | 2008 | 544 | 0.070 |
Why?
|
Guanine | 1 | 2008 | 280 | 0.070 |
Why?
|
Mycophenolic Acid | 1 | 2009 | 348 | 0.070 |
Why?
|
Magnesium Chloride | 1 | 2006 | 30 | 0.070 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17608 | 0.070 |
Why?
|
Catalytic Domain | 1 | 2009 | 699 | 0.070 |
Why?
|
Crystallography | 1 | 2006 | 110 | 0.070 |
Why?
|
Periplasm | 1 | 2006 | 43 | 0.060 |
Why?
|
Genomic Islands | 1 | 2006 | 52 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2022 | 7611 | 0.060 |
Why?
|
Amino Acid Sequence | 2 | 2009 | 13411 | 0.060 |
Why?
|
Streptococcus pyogenes | 1 | 2008 | 293 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2014 | 2056 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2009 | 2176 | 0.060 |
Why?
|
Salmonella enterica | 1 | 2004 | 75 | 0.060 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2023 | 9 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2006 | 580 | 0.060 |
Why?
|
Plasmids | 2 | 2006 | 2268 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2008 | 1494 | 0.050 |
Why?
|
Base Sequence | 1 | 2014 | 12414 | 0.050 |
Why?
|
Protein Engineering | 1 | 2007 | 554 | 0.050 |
Why?
|
Salmonella Infections | 1 | 2004 | 173 | 0.050 |
Why?
|
Animals | 10 | 2023 | 168965 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2009 | 3587 | 0.050 |
Why?
|
Mutation | 4 | 2024 | 30211 | 0.050 |
Why?
|
Klebsiella Infections | 1 | 2003 | 146 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2006 | 1750 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2003 | 253 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2011 | 6507 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 2001 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2006 | 2478 | 0.050 |
Why?
|
Kinetics | 1 | 2009 | 6287 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2014 | 857 | 0.040 |
Why?
|
Escherichia coli Infections | 1 | 2003 | 518 | 0.040 |
Why?
|
Humans | 15 | 2024 | 767040 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1893 | 0.040 |
Why?
|
Cross Infection | 2 | 2004 | 1426 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3726 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 836 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3828 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2023 | 2509 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11923 | 0.030 |
Why?
|
Genomics | 1 | 2012 | 5924 | 0.030 |
Why?
|
Position-Specific Scoring Matrices | 1 | 2014 | 11 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12790 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2023 | 4616 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 3 | 2008 | 1969 | 0.030 |
Why?
|
Megakaryocyte-Erythroid Progenitor Cells | 1 | 2014 | 10 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2493 | 0.030 |
Why?
|
Erythroblasts | 1 | 2014 | 141 | 0.030 |
Why?
|
Russia | 2 | 2004 | 383 | 0.030 |
Why?
|
Erythroid Cells | 1 | 2014 | 237 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 2013 | 216 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2008 | 7469 | 0.020 |
Why?
|
Platelet Count | 1 | 2013 | 784 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7210 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2011 | 610 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1081 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2011 | 792 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2013 | 1160 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1366 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 632 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4572 | 0.020 |
Why?
|
Directed Molecular Evolution | 1 | 2008 | 167 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2829 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23621 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22361 | 0.010 |
Why?
|
Republic of Belarus | 1 | 2004 | 38 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 2004 | 148 | 0.010 |
Why?
|
Cell Cycle | 1 | 2013 | 2927 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 2004 | 79 | 0.010 |
Why?
|
Down Syndrome | 1 | 2013 | 916 | 0.010 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2004 | 52 | 0.010 |
Why?
|
Conjugation, Genetic | 1 | 2004 | 116 | 0.010 |
Why?
|
Estradiol | 1 | 2011 | 1951 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 2003 | 114 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2008 | 877 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2252 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2887 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 766 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5796 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3567 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10869 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3667 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1729 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3610 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 2003 | 473 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9551 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3114 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4441 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12069 | 0.010 |
Why?
|
Drug Resistance | 1 | 2003 | 1592 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65295 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15567 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18989 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10455 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9513 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4780 | 0.010 |
Why?
|
Child | 1 | 2024 | 80771 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 89046 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2004 | 1761 | 0.010 |
Why?
|
Male | 1 | 2024 | 364203 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16718 | 0.000 |
Why?
|
Female | 1 | 2024 | 396660 | 0.000 |
Why?
|